Cargando…
Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928650/ https://www.ncbi.nlm.nih.gov/pubmed/36819147 http://dx.doi.org/10.1002/jha2.646 |
| _version_ | 1784888688603299840 |
|---|---|
| author | Noguchi, Kazuhiro Ikawa, Yasuhiro Takenaka, Mika Sakai, Yuta Fujiki, Toshihiro Kuroda, Rie Ikeda, Hiroko Abe, Takatoshi Sakai, Seisho Wada, Taizo |
| author_facet | Noguchi, Kazuhiro Ikawa, Yasuhiro Takenaka, Mika Sakai, Yuta Fujiki, Toshihiro Kuroda, Rie Ikeda, Hiroko Abe, Takatoshi Sakai, Seisho Wada, Taizo |
| author_sort | Noguchi, Kazuhiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9928650 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99286502023-02-16 Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration Noguchi, Kazuhiro Ikawa, Yasuhiro Takenaka, Mika Sakai, Yuta Fujiki, Toshihiro Kuroda, Rie Ikeda, Hiroko Abe, Takatoshi Sakai, Seisho Wada, Taizo EJHaem Correspondence John Wiley and Sons Inc. 2023-01-24 /pmc/articles/PMC9928650/ /pubmed/36819147 http://dx.doi.org/10.1002/jha2.646 Text en © 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Noguchi, Kazuhiro Ikawa, Yasuhiro Takenaka, Mika Sakai, Yuta Fujiki, Toshihiro Kuroda, Rie Ikeda, Hiroko Abe, Takatoshi Sakai, Seisho Wada, Taizo Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title | Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title_full | Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title_fullStr | Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title_full_unstemmed | Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title_short | Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| title_sort | acquired l1196m alk mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928650/ https://www.ncbi.nlm.nih.gov/pubmed/36819147 http://dx.doi.org/10.1002/jha2.646 |
| work_keys_str_mv | AT noguchikazuhiro acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT ikawayasuhiro acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT takenakamika acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT sakaiyuta acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT fujikitoshihiro acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT kurodarie acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT ikedahiroko acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT abetakatoshi acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT sakaiseisho acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration AT wadataizo acquiredl1196malkmutationinanaplasticlymphomakinasepositiveanaplasticlargecelllymphomaduringalectinibadministration |